|
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 40 studies with search of: | "June 15, 2005":"July 15, 2005"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] |
|
Hide studies that are not seeking new volunteers.
|
|
| 1 | Active, not recruiting | MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) | ||||
| Conditions: | HIV Infections; HIV-Associated Lipodystrophy Syndrome | |||||
| Interventions: | Drug: Lopinavir/ritonavir + zidovudine + lamivudine; Drug: Lopinavir/ritonavir + nevirapine | |||||
| 2 | Completed | Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers | ||||
| Conditions: | HIV Infections; HIV Seronegativity | |||||
| Intervention: | Biological: Lipopeptides LIPO-4 | |||||
| 3 | Recruiting | Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART) | ||||
| Condition: | HIV Infections | |||||
| Intervention: | Biological: HIV gp120/NefTat/AS02A Vaccine | |||||
| 4 | Terminated | Cellulose Sulfate (CS) Gel and HIV in Nigeria | ||||
| Conditions: | HIV Infections; Gonorrhea; Chlamydia Infections | |||||
| Intervention: | Drug: Cellulose Sulfate Vaginal Gel (Microbicide) | |||||
| 5 | Recruiting | Bangkok Tenofovir Study | ||||
| Condition: | HIV Infections | |||||
| Intervention: | Drug: Tenofovir | |||||
| 6 | Recruiting | Extended Infant Post-Exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Nevirapine; Drug: AZT; Drug: NVP and AZT; Drug: NVP; Drug: NVP+AZT | |||||
| 7 | Active, not recruiting | Effectiveness of the Diaphragm for HIV Prevention | ||||
| Condition: | HIV Infection | |||||
| Intervention: | Device: Ortho All-Flex diaphragm and Replens lubricant gel | |||||
| 8 | Completed | Improving HIV Screening With Nurse-Based Rapid Testing/Streamlined Counseling | ||||
| Conditions: | Health Care Quality, Access, and Evaluation; Delivery of Health Care; Immune System Diseases; HIV Infections | |||||
| Interventions: | Procedure: HIV test order; doctor vs. nurse vs. rapid test; Procedure: Evaluation of receipt of HIV test results between 3 modes | |||||
| 9 | Recruiting | Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Biological: HIV-1 gag DNA; Biological: IL-15 DNA adjuvant; Biological: IL-12 DNA adjuvant | |||||
| 10 | Completed | Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy | ||||
| Conditions: | Leukoencephalopathy, Progressive Multifocal; HIV Infections | |||||
| Interventions: | Drug: Enfuvirtide; Drug: Tenofovir-Emtricitabine | |||||
| 11 | Active, not recruiting | Safety of and Immune Response to a DNA HIV Vaccine Followed By an Adenoviral Vector HIV Vaccine in Healthy Adults | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Biological: VRC-HIVDNA016-00-VP; Biological: VRC-HIVADV014-00-VP; Biological: VRC-HIVDNA016-00-VP placebo; Biological: VRC-HIVADV014-00-VP placebo | |||||
| 12 | Recruiting | Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis | ||||
| Conditions: | HIV Infections; Tuberculosis | |||||
| Interventions: | Drug: efavirenz; Drug: tenofovir; Drug: emtricitabine | |||||
| 13 | Completed | "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects | ||||
| Condition: | HIV Infection | |||||
| Intervention: | Drug: Stopping nucleosides and continuing lopinavir/ritonavir monotherapy | |||||
| 14 | Recruiting | Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients | ||||
| Condition: | HIV Infections | |||||
| Intervention: | Drug: Kaletra | |||||
| 15 | Recruiting | Study of UC-781 Vaginal Microbicide | ||||
| Condition: | HIV Infections | |||||
| Intervention: | Drug: topical vaginal application of UC-781 gel | |||||
| 16 | Completed | The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients | ||||
| Conditions: | HIV Infections; Lipodystrophy | |||||
| Interventions: | Drug: Placebo; Drug: Genotropin (human recombinant Growth hormone) | |||||
| 17 | Active, not recruiting | Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS | ||||
| Conditions: | HIV Infections; Fatigue | |||||
| Intervention: | Drug: Modafinil | |||||
| 18 | Recruiting | Effectiveness of Nucleoside Supplementation and Substituting Tenofovir Disoproxil Fumarate for Other Drugs in Anti-HIV Regimens in Reversing Fat Loss in HIV Infected Adults | ||||
| Conditions: | HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders | |||||
| Interventions: | Drug: NucleomaxX; Drug: Tenofovir disoproxil fumarate | |||||
| 19 | Recruiting | Home-Based AIDS Care Project | ||||
| Condition: | HIV Infections | |||||
| Intervention: | Procedure: Laboratory and clinical monitoring regimens | |||||
| 20 | Completed | Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) | ||||
| Conditions: | HIV Infections; AIDS | |||||
| Intervention: | Drug: stavudine, efavirenz, lamivudine | |||||
| 21 | Completed | Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy | ||||
| Condition: | HIV Infections | |||||
| Intervention: | Drug: CCR5mAb004 | |||||
| 22 | Recruiting | Pediatric Nevirapine Resistance Study | ||||
| Conditions: | AIDS; HIV Infections | |||||
| Intervention: | Drug: nevirapine | |||||
| 23 | Completed | TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options | ||||
| Condition: | HIV Infections | |||||
| Intervention: | Drug: TMC114 | |||||
| 24 | Recruiting | Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Tenofovir disoproxil fumarate; Drug: Tenofovir disoproxil fumarate | |||||
| 25 | Completed | Long-Term Supervised Treatment Interruption in HIV-Infected Patients | ||||
| Condition: | HIV Infections | |||||
| Intervention: | Procedure: Treatment interruption | |||||
| 26 | Terminated | Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Indinavir; Drug: Lamivudine; Drug: Ritonavir | |||||
| 27 | Terminated | Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients | ||||
| Condition: | HIV Infections | |||||
| Intervention: | Drug: Interleukin-2 | |||||
| 28 | Completed | Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) | ||||
| Conditions: | Hyperlipidemia; HIV Infections | |||||
| Interventions: | Drug: Pravastatin; Drug: Rosuvastatin | |||||
| 29 | Completed | DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy | ||||
| Conditions: | HIV Infections; AIDS | |||||
| Intervention: | Drug: efavirenz; didanosine EC; lamivudine | |||||
| 30 | Completed | DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy | ||||
| Conditions: | HIV Infections; AIDS | |||||
| Intervention: | Drug: efavirenz, stavudine extended release, lamivudine | |||||
| 31 | Active, not recruiting | Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults | ||||
| Condition: | HIV Infections | |||||
| Intervention: | Biological: VRC-HIVADV014-00-VP | |||||
| 32 | Recruiting | Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study) | ||||
| Condition: | HIV Infection | |||||
| Intervention: | Drug: mycophenol mofetil (MMF, Cellcept®) 500 mg BID | |||||
| 33 | Recruiting | Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs) | ||||
| Conditions: | HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders | |||||
| Intervention: | ||||||
| 34 | Recruiting | Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti | ||||
| Conditions: | HIV Infections; Tuberculosis | |||||
| Interventions: | Drug: Efavirenz; Drug: Lamivudine/Zidovudine | |||||
| 35 | Withdrawn | A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects | ||||
| Conditions: | HIV Infection; Hepatitis C | |||||
| Interventions: | Drug: Kaletra (lopinavir/ritonavir); Drug: Sustiva (efavirenz); Drug: Truvada (emtricitabine/tenofovir disoproxil fumarate) | |||||
| 36 | Active, not recruiting | Efficacy of Alendronate Versus Placebo in the Treatment of HIV-Associated Osteoporosis | ||||
| Conditions: | Osteoporosis; HIV Infections | |||||
| Intervention: | Drug: Alendronate | |||||
| 37 | Completed | Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: atazanavir/ritonavir +2 NRTIs (immediate Switch Group); Drug: LPV/r +2 NRTIs (Delayed/optional Switch Group) | |||||
| 38 | Active, not recruiting | Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults | ||||
| Condition: | HIV Infections | |||||
| Interventions: | Drug: Abacavir/Lamivudine; Drug: Atazanavir; Drug: Efavirenz; Drug: Emtricitabine/Tenofovir disoproxil fumarate; Drug: Ritonavir; Drug: Abacavir/Lamivudine placebo; Drug: Emtricitabine/Tenofovir disoproxil fumarate placebo | |||||
| 39 | Terminated | Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients | ||||
| Conditions: | HIV; Peripheral Nervous System Disorders | |||||
| Intervention: | Drug: prosaptide | |||||
| 40 | Active, not recruiting | 4-Methylumbelliferone as a Treatment for Chronic HBV/HCV | ||||
| Conditions: | Chronic Hepatitis C; Chronic Hepatitis B | |||||
| Intervention: | Drug: 4-Methylumbelliferone (Heparvit®) | |||||